We are live on ! Find out more
EC

Elequin Capital Portfolio holdings

AUM $1.19B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+1.37%
1 Year Est. Return
+16.08%
3 Year Est. Return
+46.25%
5 Year Est. Return
10 Year Est. Return
AUM
$196M
AUM Growth
+$53.4M
Cap. Flow
-$20.6M
Cap. Flow %
-10.52%
Top 10 Hldgs %
68.42%
Holding
688
New
375
Increased
38
Reduced
38
Closed
155
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXON
301
Axon Enterprise
AXON
$42.3B
$9.37K ﹤0.01%
+48
New +$9.94K
AEF
302
abrdn Emerging Markets Equity Income Fund
AEF
$348M
$9.36K ﹤0.01%
1,804
-5,762
-76% -$29.8K
ARCC icon
303
Ares Capital
ARCC
$13.5B
$9.04K ﹤0.01%
+481
New +$8.88K
ITGR icon
304
Integer Holdings
ITGR
$3.42B
$9.04K ﹤0.01%
+102
New +$8.35K
PDT
305
John Hancock Premium Dividend Fund
PDT
$636M
$8.8K ﹤0.01%
+747
New +$8.89K
ABNB icon
306
Airbnb
ABNB
$90.3B
$8.71K ﹤0.01%
+68
New +$7.95K
ORA icon
307
Ormat Technologies
ORA
$5.94B
$8.61K ﹤0.01%
+107
New +$9.06K
BMRN icon
308
BioMarin Pharmaceuticals
BMRN
$11.7B
$8.58K ﹤0.01%
+99
New +$9.32K
VSH icon
309
Vishay Intertechnology
VSH
$5.18B
$8.5K ﹤0.01%
+289
New +$7.06K
CYTK icon
310
Cytokinetics
CYTK
$10.9B
$8.42K ﹤0.01%
+258
New +$9.55K
TRIS
311
DELISTED
Tristar Acquisition I Corp.
TRIS
$8.37K ﹤0.01%
800
ABR icon
312
Arbor Realty Trust
ABR
$921M
$8.36K ﹤0.01%
+564
New +$6.98K
CORS
313
DELISTED
Corsair Partnering Corporation
CORS
$8.32K ﹤0.01%
803
NXGN
314
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$8.22K ﹤0.01%
+507
New +$8.4K
EMD
315
Western Asset Emerging Markets Debt Fund
EMD
$611M
$8.21K ﹤0.01%
952
-6,558
-87% -$56.9K
TVTX icon
316
Travere Therapeutics
TVTX
$5.33B
$8.14K ﹤0.01%
+530
New +$9.64K
HFRO
317
Highland Opportunities and Income Fund
HFRO
$407M
$8.12K ﹤0.01%
+899
New +$7.86K
BOAC.WS
318
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$8.1K ﹤0.01%
+150,000
New +$10.9K
FE icon
319
FirstEnergy
FE
$28.2B
$8.05K ﹤0.01%
+207
New +$8.12K
PI icon
320
Impinj
PI
$4.49B
$7.98K ﹤0.01%
+89
New +$9.48K
CII icon
321
BlackRock Enhanced Captial and Income Fund
CII
$980M
$7.42K ﹤0.01%
+401
New +$7.19K
XYZ
322
Block Inc
XYZ
$49.2B
$7.39K ﹤0.01%
+111
New +$6.93K
PATK icon
323
Patrick Industries
PATK
$2.79B
$7.28K ﹤0.01%
+137
New +$6.45K
SOFI icon
324
SoFi Technologies
SOFI
$21.1B
$7.15K ﹤0.01%
+857
New +$5.59K
HTHT icon
325
Huazhu Hotels Group
HTHT
$13B
$7.02K ﹤0.01%
+181
New +$7.87K

Similar funds

Elequin Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Elequin Capital held 688 positions worth $196M, up 38% from $142M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Elequin Capital withdrew a net $20.6M in Q2 2023, closing 155 positions and reducing 38 holdings. Its most notable exit was Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B, an estimated $6.37M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 17% of assets, up from 0% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Elequin Capital opened a new position in Coherent Corp. 6.00% Series A Mandatory Convertible Preferred Stock worth $14.5M.

  • Elequin Capital's largest Q2 2023 buy was Coherent Corp. 6.00% Series A Mandatory Convertible Preferred Stock: 63,711 shares worth $14.5M.
  • Elequin Capital added most to Liberty All-Star Equity Fund in Q2 2023, an estimated $316K increase.
  • Elequin Capital's biggest Q2 2023 reduction was iShares Silver Trust, cutting an estimated $798K.
  • Elequin Capital fully exited Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B in Q2 2023, selling an estimated $6.37M.
  • Elequin Capital's ten largest holdings make up 68% of its $196M portfolio in Q2 2023.
  • Elequin Capital opened 375 new positions and closed 155 in Q2 2023.
  • Elequin Capital's portfolio value rose 38% quarter-over-quarter to $196M.

Based on Elequin Capital's 13F filing for Q2 2023, filed 14 Aug 2023.